We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Human Genome Sciences, Inc. (MM) | NASDAQ:HGSI | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 14.24 | 0 | 01:00:00 |
From May 2019 to May 2024
LONDON--Research-based pharmaceutical and healthcare company GlaxoSmithKline PLC (GSKl.LN) said Monday that the initial tender offer for Human Genome Sciences Inc (HGSI) expired 0400 GMT on July 26, and at that time 158.61 million shares, or 79%, had been validly tendered and not withdrawn.
MAIN FACTS:
-An additional 9.16 million Human Genome shares, or 4%, were tendered subject to guaranteed delivery procedures.
-GlaxoSmithKline shares at 1235 GMT up 17 pence, or 1.14%, at 1460 pence valuing the company at 72.03 billion pounds.
-Write to Ian Walker at ian.walker@dowjones.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Human Genome Sciences Chart |
1 Month Human Genome Sciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
